Anacor Pharmaceuticals (ANAC) jumps on positive test results

July 13, 2015 10:59 AM | 10 seconds read |
Anacor Pharmaceuticals Inc ANAC shares climbed 46.8% to $124.21 after announcing positive top-line results from atopic dermatitis studies. Share volume was 642,000, compared to an all-day average of 210,000
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!